Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry.
Marta Araujo-CastroM Paja FanoB Pla PerisM González BoillosE Pascual-CorralesA M García CanoP Parra RamírezP Martín Rojas-MarcosJ G Ruiz-SanchezA Vicente DelgadoE Gómez HoyosR FerreiraI García SanzM Recasens SalaR Barahona San MillanM J Picón CésarP Díaz GuardiolaC M PerdomoL Manjón MiguélezR García CentenoJ C PercovichÁ Rebollo RománP Gracia GimenoC Robles LázaroM Morales-RuizM Calatayud GutiérrezS A Furio CollaoD MenesesM A Sampedro NuñezV Escudero QuesadaE Mena RibasA Sanmartín SánchezC Gonzalvo DiazC LamasR Guerrero-VázquezM Del Castillo TousJ Serrano GotarredonaT Michalopoulou AlevrasE M Moya MateoF A HanzuPublished in: Journal of endocrinological investigation (2023)
DM affects about one quarter of patients with PA and the risk factors for its development are common to those of the general population. Medical and surgical treatment provides similar benefit in glycemic control in patients with PA and DM.